Potential biomarkers and challenges in glioma diagnosis, therapy and prognosis
Gliomas are the most common central nervous system malignancies and present with significant morbidity and mortality. Treatment modalities are currently limited to surgical resection, chemotherapy and radiotherapy. Increases in survival rate over the previous decades are negligible, further pinpoint...
Main Authors: | Mastura Monif, Liyen Katrina Kan, Kate Drummond, Martin Hunn |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2020-12-01
|
Series: | BMJ Neurology Open |
Online Access: | https://neurologyopen.bmj.com/content/2/2/e000069.full |
Similar Items
-
A Simple and Reliable Protocol for the Preparation and Culturing of Fresh Surgically Resected Human Glioblastoma Tissue
by: Liyen Katrina Kan, et al.
Published: (2020-01-01) -
Plasma specific miRNAs as predictive biomarkers for diagnosis and prognosis of glioma
by: Wang Qiong, et al.
Published: (2012-11-01) -
PDIA4 Correlates with Poor Prognosis and is a Potential Biomarker in Glioma
by: Li H, et al.
Published: (2021-01-01) -
MicroRNAs as potential biomarkers for diagnosis, therapy and prognosis of gastric cancer
by: Yuan HL, et al.
Published: (2018-07-01) -
Analysis of Long Noncoding RNA ZNF667-AS1 as a Potential Biomarker for Diagnosis and Prognosis of Glioma Patients
by: Qin Yuan, et al.
Published: (2020-01-01)